Mei-Ling Liou

817 total citations
11 papers, 679 citations indexed

About

Mei-Ling Liou is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Mei-Ling Liou has authored 11 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Mei-Ling Liou's work include NF-κB Signaling Pathways (5 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Mei-Ling Liou is often cited by papers focused on NF-κB Signaling Pathways (5 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Mei-Ling Liou collaborates with scholars based in United States and Taiwan. Mei-Ling Liou's co-authors include Hsiou‐Chi Liou, Zhuang Jin, Joseph R. Tumang, Sofija Andjelić, Gokul Kandala, Kendall A. Smith, Yeong Jin Choi, Ming‐Zong Lai, Richard R. Hardy and Alexander M. Owyang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Mei-Ling Liou

11 papers receiving 670 citations

Peers

Countries citing papers authored by Mei-Ling Liou

Since Specialization

Citations

This map shows the geographic impact of Mei-Ling Liou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Liou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Liou more than expected).

Fields of papers citing papers by Mei-Ling Liou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Ling Liou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Liou. The network helps show where Mei-Ling Liou may publish in the future.

Co-authorship network of co-authors of Mei-Ling Liou

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Ling Liou. A scholar is included among the top collaborators of Mei-Ling Liou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Ling Liou. Mei-Ling Liou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control 2024 ·Frontiers in Medicine ·Anshika Jain, Gaspar E. Cánepa, Mei-Ling Liou, (unknown), Andrei I. Chapoval, (unknown), (unknown), (unknown), (unknown), (unknown), Princy Kumar, José Bordón, Marcus A. Conant, Jefferey S. Boyle	1
2	Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models 2022 ·Frontiers in Immunology ·Mei-Ling Liou, Tyler Lahusen, Haishan Li, (unknown), C. David Pauza	2
3	Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local 2018 ·Frontiers in Immunology ·C. David Pauza, Mei-Ling Liou, Tyler Lahusen, (unknown), Rena G. Lapidus, Cristiana Cairo, Haishan Li	81
4	Direct Rel/Nf-κB Inhibitors: Structural Basis for Mechanism of Action 2009 ·Future Medicinal Chemistry ·Samedy Ouk, Mei-Ling Liou, Hsiou‐Chi Liou	10
5	BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten 2008 ·Cell Research ·Shuhua Cheng, Constance Y. Hsia, Biao Feng, Mei-Ling Liou, (unknown), Pier Paolo Pandolfi, Hsiou‐Chi Liou	38
6	c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function 1999 ·International Immunology ·Hsiou‐Chi Liou, Zhuang Jin, Joseph R. Tumang, Sofija Andjelić, Kendall A. Smith, Mei-Ling Liou	161
7	The Ubiquitin-homology Protein, DAP-1, Associates with Tumor Necrosis Factor Receptor (p60) Death Domain and Induces Apoptosis 1999 ·Journal of Biological Chemistry ·Mei-Ling Liou, Hsiou‐Chi Liou	29
8	c-Rel is essential for B lymphocyte survival and cell cycle progression 1998 ·European Journal of Immunology ·Joseph R. Tumang, Alexander M. Owyang, Sofija Andjelić, Zhuang Jin, Richard R. Hardy, Mei-Ling Liou, Hsiou‐Chi Liou	112
9	CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. 1996 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Gokul Kandala, Mei-Ling Liou, Hsiou‐Chi Liou, Yeong Jin Choi	160
10	cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. 1993 ·The Journal of Immunology ·(unknown), Mei-Ling Liou, Yang Yang, Ming‐Zong Lai	54
11	Isolation and characterization of nuclear proteins that bind to T cell receptor V beta decamer motif 1992 ·The Journal of Immunology ·(unknown), Cheng‐Yu Chung, Mei-Ling Liou, Manxi Wu, (unknown), Yi‐Ping Hsueh, Ming‐Zong Lai	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact